A gene-based therapy to stop the rodent equivalent of the autoimmune disease myasthenia gravis by specifically targeting the destructive immune response the disorder triggers in the body was developed by John Hopkins researchers while working with mice. The technique, the result of more than 10 years of work, holds promise for a highly specific therapy for the progressively debilitating muscle-weakening human disorder, one that avoids the need for long-term, systemic ...Wednesday 3 October 2012
Autoimmune Disease Myasthenia Gravis Halted in Mice By Researchers
A gene-based therapy to stop the rodent equivalent of the autoimmune disease myasthenia gravis by specifically targeting the destructive immune response the disorder triggers in the body was developed by John Hopkins researchers while working with mice. The technique, the result of more than 10 years of work, holds promise for a highly specific therapy for the progressively debilitating muscle-weakening human disorder, one that avoids the need for long-term, systemic ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment